Its antitumor activity has been previously reported in both in vitro and in xenograft studies of breast cancer cell lines [77], [78], but the possibility that this activity could be due to inhibition of the ALDH5A1 isoform was not previously considered. The gene discussed is ALDH5A1; the disease is breast carcinoma.